Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

5.9K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.9K
Hormonal Regulation01:33

Hormonal Regulation

35.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Alterations in Nitric Oxide Production After Post-Weaning Social Isolation.

Physiological research·2026
Same author

From Synapsia to Ideas: Nitric Oxide and Sensory Roots of Knowledge.

Physiological research·2026
Same author

Nitric Oxide at the Nexus of ACE2 Biology and COVID-19: Implications for Cardiovascular and Neurodegenerative Comorbidities.

Physiological research·2026
Same author

Cardio-Renal Effects of Short-Term Fructose Treatment in Hypertensive Rats: Focused on NO/ROS Balance.

Physiological research·2026
Same author

Modulation of Cardiac Gene Expression by anti-HMGB1 in a Model of Experimental Myocardial Infarction.

Physiological research·2026
Same author

Mitochondrial Peroxiredoxins and Monoamine Oxidase-A: Dynamic Regulators of ROS Signaling in Cardioprotection.

Physiological research·2025

相关实验视频

Updated: Jan 15, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

18.4K

联合RAS调节:对血和组织 ангиотензин水平的影响

L Paulis1, R Rajkovicova, K Repova

  • 1Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.

Physiological research
|January 14, 2026
PubMed
概括

联合宁-血管素系统 (RAS) 阻塞改善了血压,但没有改善结果. 双重封锁可能会降低有益的Ang1-7,这表明需要谨慎的治疗策略.

更多相关视频

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.0K
Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
07:21

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

39.0K

相关实验视频

Last Updated: Jan 15, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

18.4K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.0K
Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
07:21

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

39.0K

科学领域:

  • 心血管研究研究心血管研究
  • 药理学 药理学是指药理学的学科.
  • 高血压管理 高血压管理

背景情况:

  • 联合宁-血管素系统 (RAS) 抑制可以改善血压控制,但不能改善临床结果.
  • 血管素形状的复杂变化在联合RAS阻塞中至关重要.
  • 自发高血压大鼠 (SHR) 呈现高血压和心脏缩.

研究的目的:

  • 在联合RAS阻塞下研究SHR中的血液动力学和血管素形状.
  • 评估利西诺普里尔,奥尔梅沙坦,阿利斯基伦及其双重组合的作用.
  • 了解对循环和组织血管酶的影响.

主要方法:

  • 用利西诺普里尔,奥尔梅沙坦,阿利斯基伦和双重组合治疗SHR.
  • 测量血液动力学,血压和心脏形态.
  • 对循环和组织血管素形状 (Ang I,Ang II,Ang 1-7) 的分析.

主要成果:

  • 利西诺普里尔显示出最强大的抗高血压作用,通过组合增强.
  • 在这种低RAS设置中,阿利斯基伦的效果适度.
  • 双重RAS阻塞经常减少脏和循环Ang1-7,尽管血液动力学疗效.
  • 左心室Ang II主要来自循环来源,而脏合成显示了局部酶活性.

结论:

  • 联合RAS封锁需要谨慎的,意识到机制的方法.
  • 治疗策略应平衡降低血压与Ang 1-7轴的维护.
  • 了解组织特异性合成是优化RAS抑制的关键.